h y p o c a l c a e m i a a n d c o m p e n s a t o r y hyperparathyroidism. But with advancing disease, the compensatory mechanism can no more maintain the mineral homeostasis and biochemical a b n o r m a l i t i e s l i k e h y p e r p h o s p h a t e m i a , hypocalcaemia and hyperparathyroidism become obvious at stage 4 CKD. 3, 4 Besides, decreased kidney function, lack of adequate storage of vitamin D (25, OH vitamin D / calcidiol) is responsible for decreased calcitriol synthesis and its consequences in CKD. 5 Studies have shown vitamin D deficiencies (20-29 ng/ml) and insufficiency (<20 ng/ml) in CKD, both in pre dialysis and maintenance hemodialysis patients,
INTRODUCTION
Chronic kidney disease (CKD) is a modern day global epidemic with high cardiovascular morbidity and mortality. 1 As kidney function declines, there is progressive and interrelated deterioration in mineral homeostasis with altered serum concentration of phosphorus, calcium, vitamin D and parathyroid hormone (PTH), bone abnormalities, vascular and soft tissue calcification and finally increased cardiovascular disease. 2 Initially, transient retention of phosphorus, due to failing kidney, results decreased activity of renal 1-a hydroxylase in proximal tubule with decreased calcitriol (1, 25 OH2 vitamin D) synthesis there by probably due to its prevalence in general population or due to different factors related to CKD has predisposed low vitamin D level with its greater incidence in CKD compared to healthy control. [6] [7] [8] Apart from calcitrophic effects, vitamin D has multiple beneficial effects in the body and h y p o v i t a m i n o s i s D r e s u l t s i n i n c r e a s e d cardiovascular mortality in CKD as vitamin D supplementation in these patients had decreased cardiovascular risk with increased survival. 6, 9, 10 Prevalence of hypovitaminosis D in 73.7% healthy Nepalese population and 89.1% patients with different health related problem were reported. 11, 12 But there is no reported study on status of vitamin D level and its calcitrophic and non calcitrophic effects in Nepalese CKD patients. So this is the first study of its kind carried out to find out the status serum vitamin D level and its relation with calcium and phosphorus in Nepalese pre-dialysis CKD patients.
METHODS
It was a hospital-based cross sectional study carried out in Department of Nephrology, National Academic of Medical Science (NAMS), Bir Hospital from June 2016 to August 2016 after approval by Institutional Review Board (IRB), NAMS. All consecutive pre-dialysis patients of stage 3-5ND (Non-Dialysis) were enrolled after taking informed written consent. Patients with age less than 18 years, acute on CKD, on hemodialysis, and those receiving vitamin D or its analogues, calcium supplements, phosphate binders and corticosteroids were excluded.
Pre-designed pro-forma was used for data collection. Patient's name, age, sex, history of hypertension and diabetes mellitus, blood pressure, height and weight were recorded. Then 10 ml venous blood samples without tourniquet were drawn from each participant to estimate of serum creatinine, urea, albumin, calcium and phosphorus by Ebra Mannheim XL SysPack kit and vitamin D by automated Chemiluminescent Immunoassay technology. All data were first entered in the excel spread sheet for calculating different parameters and grouping of study population. 14 . Corrected calcium was calculated by using the equation-Corrected Calcium = measured Ca + 0.8 (4.0 -albumin). 5 According to laboratory parameters the CKD patients were grouped in to vitamin D sufficient (>30 ng/ml), insufficient (20 to 30 ng/ml) and deficient (<20 ng/ml) 6 and corrected calcium < 8.5 mg% and >10.5 mg % as hypocalcemia and hypercalcemia respectively, and serum phosphorus <2.5 mg% and >4.5 mg% as hypophosphatemia & hyperphosphatemia respectively. 15 Statistical analysis: Data analysis was performed by SPSS soft-ware package 19.0. Continuous variables were presented as mean+SD. ANOVA and Chi-square tests were applied as the test of significance and p < 0.05 was taken as level of significance. Associations between vitamin D status and various stages of CKD were calculated by multivariate logistic regression analysis.
RESULTS
A total of sixty six patients were included in this study with male 51 (77.3%) and female 15 (22.7%) and age (mean ± SD) 54.3 ± 14.8 years.
The distribution of patients in different CKD stages were stage 3a (15.2%), stage 3b (37.9%), stage 4 (22.7%) and stage 5ND (24.2%) with significantly increasing serum creatinine and decreasing eGFR as shown in Table 1 (Table  5) .
Pearson correlation coefficient study showed no correlation of serum vitamin D with eGFR (r= 0.212, p = 0.087) and corrected calcium (r = 0.096, p = 0.443, Fig 1) and significant negative correlation with phosphorus (r = -0.248, p = 0.045, Fig 2) . Serum phosphorus had significant negative correlation with eGFR (r = -o.6, p < 0.001) and no correlation with corrected calcium (r = -0.109, p = 0.385, Fig 3) . Moreover, Nepal lies in temperate zone and low vitamin D is highly p r e v a l e n t i n N e p a l e s e h e a l t h y p e o p l e 11 , hypovitaminosis in our cohort could have reflected its prevalence here rather than the effect of CKD on vitamin D and further comparable studies on status of vitamin D in CKD and healthy control along with their dietary status will verify these findings.
DISCUSSION
Hypocalcemia is a part of abnormal mineral metabolism in CKD and becomes obvious from stage 4 CKD 3,4 . Hypocalcemia is mainly due to decreased absorption from intestine secondary to inadequate vitamin D and deposition of calcium and phosphorus product in bone secondary to hyperphosphatemia in CKD. 22 Hyperphosphatemia is the independent predictor of increased cardiovascular mortality 23 . High prevalence of hyperphosphatemia in pre-dialysis CKD has been reported from different parts of the world with 69.4% in Nigeria 8 and 53.7% to 64.1% in India 18 . Contrary to serum calcium, serum phosphorus showed gradual increment with rise of CKD stage indicating inverse relation with e G F R 1 8 , 2 1 , 2 2 S i m i l a r l y, w e a l s o f o u n d hyperphosphatemia in 63.6% patients and mean phosphorus level gradually increased with increasing CKD stage with significant negative correlation with eGFR (r = -o.6, p < 0.001). Serum phosphorus level remained within normal limit in stage 3a and 3b and become high in stage 4 and 5ND indicating phosphorus hemostasis could no more be maintained once eGFR is < 30 ml/min even in our cohort. Moreover, hyperphosphatemia causes reduced synthesis of calcitriol and secondary hyperparathyroidism which causes increased degradation of vitamin D with decreased substrate for calcitriol synthesis 5 . Although direct effect of serum phosphorus on vitamin D is not well known, inverse relation of serum phosphorus and vitamin D in CKD has been documented in several studies 17, 21 including in our patients.
CONCLUSIONS
H y p o v i t a m i n o s i s D , h y p o c a l c e m i a a n d hyperphosphatemia are common in pre-dialysis CKD patients with no difference of incidence of hypovitaminosis and hypocalcemia in different stages of CKD. There is significantly higher incidence of hyperphosphatemia with decreasing eGFR and increasing CKD stages.
